CDK4 and Miyoshi myopathy: Significant growth-inhibition was seen in all MM cell lines after 72 h treatment with CDK4/6i (IC50 0.4–2 μM): 80% cell-death was noted in both RAS-WT and RAS-MT cells (P < 0.005) (Fig. 1B6, Fig. S2).